Gensaic is a redosable genomic medications company that seeks to reimagine gene therapy.
Gensaic has raised $3.5M in total funding. The most recent round was Grant. The last funding was announced in January 2023.
Gensaic's investors include Cystic Fibrosis Foundation.
Gensaic is headquartered in Cambridge, United States.
Gensaic is a redosable genomic medications company that seeks to reimagine gene therapy.
Gensaic is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Gensaic — Funding & Investors." VCBacked, January 9, 2023, https://www.vcbacked.co/company/gensaic. Accessed October 6, 2026.
VCBacked. (2023). Gensaic — Funding & Investors. Retrieved October 6, 2026, from https://www.vcbacked.co/company/gensaic
{{cite web |title=Gensaic — Funding & Investors |url=https://www.vcbacked.co/company/gensaic |website=VCBacked |access-date=October 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated